BMS’ and bluebird bio’s Abecma approved by US FDA; first CAR T cell therapy for multiple myeloma Bristol Myers Squibb and bluebird bio, Inc. announced that the US Food and Drug Administration approved Abecma (idecabtagene vicleucel;...
Novartis’ blockbuster Entresto received the US FDA approval for a broader target population Novartis has received the US FDA approval of Entresto ((sacubitril/valsartan) for the broader target population; it is now approved for...
Merck and Bayer announced the US FDA approval for Verquvo Merck and Bayer have announced that the companies have received the US FDA's approval for Verquvo (vericiguat). The drug is approved for...
Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients Biogen has announced that the first patient with spinal muscular atrophy (SMA) has been treated with Spinraza (nusinersen), who were...
Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile Johnson and Johnson announced that it will acquire Momenta Pharmaceuticals for an all cash transaction worth of $6.5 billion. Momenta...
Lynparza was approved for three more indications in Japan AstraZeneca and Merck announced that Lynparza (olaparib) was approved for three more indications in Japan. The three new cancer...
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients Gilead has announced top-line Phase 3 trial results of remdesivir in patients with COVID-19. The drug is indicated in moderate COVID-19...
Astellas received approval for Xtandi in Japan for prostate cancer Astellas announced that it had received approval from Japan Ministry of Health, Labour and Welfare (MHLW) for Xtandi (enzalutamide) for...
Roche’s Rozlytrek approved in Australia for ROS1 positive NSCLC Australia’s Therapeutic Goods Administration has approved Rozlytrek (entrectinib) for treating patients suffering from ROS1 positive...
ipharmaservices Mar 12 2 min Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System
ipharmaservices Jan 12 1 min Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
ipharmaservices Aug 25, 2020 2 min Merck’s Keytruda received one more indication and dosage form approval in Japan
